Pluripotent Stem Cell Fate *in utero* and *in vitro* {#S1}
====================================================

Pluripotency describes the developmental capacity of a cell to form the three primary germ layers, which in turn can give rise to all cell types of the adult body. As such it does not represent a single fixed stage, but rather a gradient of cellular phenotypes from the "naïve" pluripotent stem cells (PSCs) of the inner cell mass (ICM) of the early blastocyst, to the "primed" PSCs of the early post-implantation epiblast ([@B160]). Upon uterine implantation, the epiblast cells progressively lose expression of core pluripotency genes Oct4 and Nanog as the three germ layers emerge during gastrulation ([@B160]; [@B93]). The expression of these transcription factors is spatially restricted and ultimately suppressed by the time of somitogenesis ([@B106]).

Although pluripotency exists transiently *in vivo*, several stages can be stably recapitulated *in vitro* ([@B37]). Embryonic stem cells (ESCs) derived from the ICM of murine blastocysts are considered the developmental naïve state in terms of their transcriptional activity, epigenetics and metabolic phenotypes ([@B102]; [@B160]). General characteristics of naïve PSCs include the ability to give rise to all somatic lineages, incorporate into a developing blastocyst generating chimeric embryos, two active X chromosomes in female lines and the utilization of bivalent metabolism \[both glycolysis and oxidative phosphorylation (OxPhos)\] ([@B160]). While original protocols required leukemia inhibitory factor (LIF) and serum supplementation to maintain this naïve state, serum is dispensable upon the addition of GSK3 and MEK inhibitors (2i) ([@B164]). In contrast, when cells are derived from the post-implantation epiblast they are termed epiblast stem cells (mEpiSCs) and are considered a primed PSC, representative of a later developmental stage of pluripotency, and as such are functionally different from naïve PSCs ([@B11]; [@B141]). Characteristics of primed PSCs do overlap with those of naïve PSCs, yet there are notable differences: primed PSCs express the core pluripotency genes Oct4, Sox2, and Nanog, however they are not capable of integrating into a developing blastocyst to form chimeric embryos, they are predominantly glycolytic, and inactivation of one X chromosome has been noted in female lines ([@B160]). Interestingly mEpiSCs can be cultured *in vitro* without LIF when in the presence of fibroblast growth factor (FGF) and activin A ([@B11]; [@B141]).

Unlike mESCs, human ESCs (hESCs) derived from the ICM of the human blastocyst resemble a primed rather than naïve state ([@B145]) ([Figure 1](#F1){ref-type="fig"}). This aligns hESCs more closely with mEpiSCs in terms of their culture requirements, as well as their transcriptional and epigenetic profiles. Reviews by [@B31] and [@B160] discuss the growing body of literature highlighting the differences between naïve and primed ESCs from murine and human epiblasts in terms of transcriptomic, epigenetic and chromosomal profiles, and postulate these differences are likely the result of species specific developmental programs and requirements. A stable naïve state can be generated by culturing primed hESCs in a cocktail of MEK, RTK, BRAF, ROCK, and GSK3β inhibitors, in addition to LIF and activin A (5i/L/A) or titrated 2i with LIF and PKC inhibitor Gö6983 (t2iLGö) ([@B138]; [@B144]). Similar conditions with the addition of ROCK inhibitor and ascorbic acid (t2iLGöY) have also been utilized to derive naïve ESCs from the human ICM ([@B56]). The resultant naïve hESCs recapitulate the features of mESCs, including X chromosome reactivation in female cell lines. Interestingly, inhibition of Rho kinase with the ROCK inhibitor Y-27632 in single cell hESCs dissociated by enzymatic methods initially results in the suppression of glycolysis, TCA cycle, and glutaminolysis, while promoting cell survival by inhibiting caspase-3 mediated apoptosis ([@B154]). Prolonged culture in ROCK inhibitor (\>96 h) results in metabolic adaptation, after which hESC metabolism rebounds with both glycolysis and oxidative metabolism upregulated, an adaptation observed and attributed to the naïve hESC state. Whether the inclusion of ROCK inhibitor in media optimized for the generation of naïve hESCs functions primarily to couple metabolic flux with proliferation, or to inhibit apoptosis in the development of the naïve state is unclear.

![Transitions between human pluripotent stem cell (PSC) states. Human embryonic stem cells derived from the inner cell mass of the blastocyst or through nuclear reprogramming traditionally display a primed state associated with bivalent metabolism using both glycolysis and oxidative phosphorylation (OxPhos). Methods have now been developed to derive naïve PSCs (t2iLGö ± Y, RSeT) or to transition cells from the primed to naïve state (5i/L/AF, or Klf4, Nanog, 2i/L), resulting in a transition from bivalent metabolism to nearly exclusively glycolysis. These metabolic preferences reflect those of the related stage during embryonic development.](fcell-08-00087-g001){#F1}

Given ethical concerns and restrictions in deriving human ESC lines, combined with the fact that hESCs can only yield allogenic options for cell-based therapies; nuclear reprogramming has paved the way for the generation of patient derived induced pluripotent stem cells (iPSCs) ([@B137]; [@B136]). This technology utilizes the exogenous expression of core pluripotency transcription factors OCT4, SOX2, KLF4, and c-MYC to reprogram somatic cells to a pluripotent state, producing human iPSCs comparable to primed human ESCs. In contrast, nuclear reprogramming of somatic murine cells results in pluripotency more reminiscent of naïve mESCs, which may be due to a better understanding of the mediators of the murine naïve pluripotent state, as it has recently been demonstrated that parallel isogenic primed and naïve iPSCs can be derived by using media supporting the naïve state, RSeT and T2iLGö ([@B71]).

Distinct developmental stages are associated with specific patterns of metabolic activity, and growing evidence supports the concept that early metabolic changes are critical for regulating epigenetics and establishing cellular identity. Cells constantly modulate their metabolic state in response to nutrient availability, extracellular signals and reprogramming/differentiation cues, which induces changes in the concentrations of key intermediary metabolites that can serve as cofactors for the epigenetic regulation of gene transcription, including histone methylation and acetylation. This crosstalk between intermediary metabolism and epigenetics may in part account for how metabolic pathways can contribute to stem cell fate determination. In the context of pluripotency, studies have focused on several key metabolites, including S-adenosylmethionine (SAM), alpha-ketoglutarate (αKG) and acetyl-CoA, that sit at the nexus between intermediary metabolism and epigenetics. For example, methylation of discrete residues on histones play a fundamental role in regulating ESCs differentiation and pluripotent state. PSCs have chromatin characterized by "bivalent" domains, which are regulatory regions containing both an activating histone modification, histone H3 lysine 4 trimethylation (H3K4me3), and a repressive modification, histone H3 lysine 27 trimethylation (H3K27me3), which poise developmental genes to maintain their repression in the absence of differentiation signals, yet allow timely activation ([@B6]). Indeed, these critical histone marks for regulation of pluripotency and differentiation are in part regulated through metabolism ([@B67]). H3K4me3 is dependent on SAM levels derived through one-carbon metabolism from exogenous or glucose-derived serine, threonine or methionine metabolism ([@B123]; [@B121]). Repressive H3K9me3 and H3K27me3 marks are regulated in an αKG-dependent manner through demethylation by JmjC-domain containing histone demethylases (JHDMs) and ten-eleven translocation (TET) enzymes ([@B67]). H3K27 can also be acetylated, which marks enhancer regions and areas of elevated transcriptional activity. Acetylation is dependent on acetyl-CoA derived from glycolysis, which is critical for the regulation of pluripotency versus differentiation ([@B14]; [@B142]; [@B146]; [@B150]). The mechanisms by which metabolism regulates epigenetics have been reviewed extensively elsewhere ([@B116]; [@B63], [@B61]). This review focuses on the major metabolic pathways ([Figure 2](#F2){ref-type="fig"}) that influence PSC identity and how they change, or can be modulated, to support acquisition of pluripotency through nuclear reprogramming and transition between the distinct stages of pluripotency ([Figure 3](#F3){ref-type="fig"}).

![Overview of the major metabolic pathways in pluripotent stem cells and their regulators. Major metabolic pathways are found in blue boxes and key sites of regulation are highlighted in blue rectangles. Identified upstream regulators of metabolic pathways are depicted as orange rectangles and the directionality of regulation represented by red bars (suppression) or green arrows (activation).](fcell-08-00087-g002){#F2}

![Metabolic preferences of naïve and primed pluripotent stem cells (PSCs). Major metabolic pathways identified in PSCs are listed on the left and arrows depicting directionality (yellow = elevated, blue = suppressed) and magnitude (thickness) of differences relative to somatic cells.](fcell-08-00087-g003){#F3}

Pluripotent Stem Cell Metabolism {#S2}
================================

Glycolysis {#S2.SS1}
----------

High glycolytic flux is common to various stem cell populations and is critical for the acquisition and maintenance of pluripotency ([@B38]; [@B22]; [@B76]; [@B151], [@B152]; [@B127]; [@B174]; [@B45], [@B42]; [@B107]; [@B139]). Glycolysis is a sequence of cytosolic redox reactions that convert a single glucose molecule into two pyruvate molecules coupled with the generation of two net ATP and two reduced NADH molecules. While glycolysis is less energetically efficient compared to the complete oxidation of glucose in the tricarboxylic acid (TCA) cycle and OxPhos, this pathway can occur in the absence of oxygen and enables a fast rate of ATP production that can surpass that of oxygen-dependent respiration when glucose is abundant, as is the case in cell culture. In fact, ATP/ADP ratios seem to be unaffected by this metabolic preference in these cell types ([@B57]). Indeed, highly proliferating cell types typically utilize glycolysis despite sufficient oxygen availability to support oxidative metabolism (aerobic glycolysis), as incomplete oxidation of glucose enables the conservation of carbon biomass required for biosynthesis of cellular components needed for daughter cell generation ([@B149]; [@B89]). Glycolytic intermediates can also be shunted into different pathways to meet the high anabolic demands of proliferating cells: lipid synthesis via dihydroxyacetone phosphate and acetyl-CoA, and nucleotide and NADPH synthesis through glucose-6-phosphate and the Pentose Phosphate Pathway (PPP). The importance of the anabolic utilization of glycolytic intermediates is highlighted by ^13^C-labeling studies that confirm the utilization of glucose-derived carbons in the manufacturing of nucleotides and amino acids such as serine ([@B55]; [@B81]). The preferential utilization of glycolysis over mitochondrial oxidative metabolism may also represent a mechanism to preserve the genomic integrity of PSCs by reducing reactive oxygen species (ROS) produced by OxPhos and limiting subsequent damage of nuclear and mitochondrial DNA as well as reducing oxidation of proteins and lipids ([@B110]).

Although glycolytic flux is common across all stages of pluripotency, the relative contributions of glycolysis versus OxPhos do vary. The primed pluripotent state of hPSCs and mEpiSCs is almost exclusively glycolytic ([@B141]; [@B102]; [@B138]; [@B144]), whereas naïve hPSCs and mESCs utilize a bivalent metabolic system with a greater reliance on oxidative metabolism ([@B80]; [@B173]; [@B126]; [@B101]; [@B17]). Indeed, early preparatory phase glycolytic metabolites such as fructose 1, 6-bisphosphate are enriched in primed PSCs without accumulation of downstream metabolites, suggesting that these glycolytic intermediates may be consumed for anabolism or one-carbon metabolism ([@B141]; [@B173]; [@B51]; [@B138]; [@B131]). In contrast, naïve hESCs exhibited both higher glucose and oxygen consumption, coupled with elevated lactate production compared to their primed counterparts ([@B55]). This suggests that naïve pluripotent cells may reside in a hypermetabolic state, however, further investigation is needed to understand the exact mechanisms and purpose behind this high energetic requirement in the naïve state ([@B55]). These metabolic preferences may reflect substrate availability and metabolic regulation during early embryogenesis, which has been reviewed extensively elsewhere ([@B52]; [@B42]; [@B122]; [@B47]; [@B53]; [@B171]). The early embryo displays low glycolytic rates due the inhibition of hexokinase and phosphofructokinase 1 and is dependent on pyruvate supplied by ovarian follicle cells to support oxidative metabolism, with glycolysis progressively increasing during development due to higher glucose availability and glucose transporter expression ([@B5]; [@B108]).

Core pluripotency factors have been demonstrated to directly regulate glycolysis in PSCs ([@B42]; [@B169]). OCT4 directly regulates transcription of hexokinase 2 and pyruvate kinase M2 ([@B72]), consistent with the preference of these isoforms in iPSCs ([@B45]; [@B113]; [@B114]). Recently a SOX2, OCT4, and NANOG binding site has been described at the GLUT1 enhancer, which appears to increase GLUT1 expression and downstream glycolytic flux in ESCs ([@B166]). Additionally, c-MYC has been identified as a strong driver of glycolysis in both the naïve and primed pluripotent states ([@B46]; [@B55]). Myc expression is regulated through a miR-290/371-MBD2 pathway, with miR-290/371 repressing MBD2 and leading to increased expression of Myc and its downstream transcriptional targets PKM2 and LDHA, supporting elevated glycolysis ([@B13]). The RNA binding protein LIN28a/b, which plays critical roles in embryonic development, acquisition, and maintenance of pluripotency, and the transition between naïve and primed pluripotency has been demonstrated to regulate glycolysis in addition to a number of metabolic pathways, including maintaining low mitochondrial function, one-carbon metabolism, and nucleotide metabolism ([@B124]; [@B170]).

A number of upstream regulators have been implicated in regulating the metabolic phenotype during the transition between the naïve and primed state. Early work demonstrated that HIF1α is sufficient to drive the glycolytic phenotype in the primed state through activin/nodal signaling ([@B173]). More recently Ras has been implicated in controlling a number of events that are critical for the transition from naïve to primed pluripotency, including stimulation of glycolysis, epithelial-mesenchymal transition (marked by an increase in N-Cadherin) and an increase in H3K27me3. Interestingly, blocking glycolysis reversed the effect of Ras on N-Cadherin and H3K27me3, suggesting these effects are downstream of the metabolic remodeling ([@B2]). Recent work has demonstrated that downregulation of SIRT2 and upregulation of SIRT1 are a molecular signature of primed hPSCs, and that these NAD-dependent deacetylases regulate primed pluripotency through distinct mechanisms ([@B17]). The authors observed that miR-200c5p, an OCT4 induced miRNA, can directly downregulate SIRT2 mRNA and protein expression leading to hyper-acetylation of glycolytic enzymes (aldolase, glyceraldehyde-3-phosphate dehydrogenase, phosphoglycerate kinase, enolase, and pyruvate kinases) and acceleration of glycolysis. Knockdown of SIRT2 also suppressed OxPhos in fibroblasts by an unknown mechanism, enabling a higher efficiency of nuclear reprogramming. In contrast, SIRT1 expression is upregulated in primed pluripotency and inhibition of its upstream miRNA-34a, while increased SIRT1 expression promotes nuclear reprogramming ([@B80]; [@B17]). However, SIRT1 appears to elicit its downstream effects independent of metabolic regulation, potentially through the deacetylation of SOX2 and p53 leading to increased Nanog expression, and p21 inhibition ([@B80]; [@B126]; [@B101]). miRNA-34a deficiency can also endow PSCs with features of totipotent blastomeres, suggesting that these pathways may also play an important role in restricting pluripotent developmental potential ([@B23]).

Downstream of glycolysis, the fate of pyruvate has been increasingly recognized to regulate stem cell function ([@B41]; [@B118]). Pyruvate represents the nexus of multiple metabolic pathways and can be metabolized to: (a) acetyl-CoA by pyruvate dehydrogenase (PDH) to enable entry and subsequent oxidation in the TCA cycle, (b) lactate by lactate dehydrogenase (LDH), in part to enable regeneration of NAD^+^ to support high glycolytic rates, and (c) oxaloacetate by pyruvate carboxylase to anapleurotically replenish TCA cycle intermediates that are being utilized for anabolic pathways. In PSCs, pyruvate is largely metabolized to lactate, with the remaining being catabolized in the TCA cycle, in contrast to differentiated cells where pyruvate is mainly catabolized. Multiple enzymes responsible for pyruvate flux into the TCA cycle are differentially regulated in naïve *versus* primed PSCs, such as pyruvate dehydrogenase kinase (PDK) ([@B173]). For example, in primed PSCs, transport of pyruvate to the mitochondria is tightly regulated by HIF1α-induced expression of PDK 1-3, which phosphorylates and inhibits PDH, thus pushing pyruvate to lactate production ([@B93]). It was also found that UCP2, an ATP uncoupling protein, blocks the uptake of pyruvate into the TCA cycle ([@B168]). Interestingly, a recent study demonstrated that supplementing hESC media with exogenous pyruvate enhanced OxPhos while suppressing glycolysis, but had no impact on expression of pluripotent markers such as *Nanog, Pou5f1*, and *Sox2*, although this metabolic shift supported mesodermal differentiation through activation of the AMPK/mTOR pathway ([@B130]). In summary, regulation of glycolytic flux plays an important role in the acquisition of pluripotency, and more specifically, maintenance and transition between the naïve and primed states.

Mitochondrial Metabolism {#S2.SS2}
------------------------

Mitochondria are complex, highly dynamic organelles that are critical for the maintenance of cellular homeostasis, in part due to their canonical role as the major energy generator of the cell. Beyond their role in ATP generation, mitochondria play many other roles within the cell including ROS production, calcium homeostasis, cellular signaling pathways, and synthesis of metabolites, such as fatty acids, amino acids, iron/sulfur clusters, pyrimidines, heme, and steroid hormones ([@B115]; [@B34]; [@B32]; [@B120]). Over the past decade, it has become increasingly recognized that mitochondrial dynamics also significantly impact stem cell function and fate ([@B84]; [@B77]; [@B90]; [@B12]; [@B48]; [@B43]; [@B69]; [@B96]). In general, compared to their differentiated counterparts, PSCs have fewer small and globular mitochondria containing poorly developed and immature cristae, that are localized in the perinuclear region ([@B134]; [@B22]; [@B88], [@B87]; [@B39]; [@B3]; [@B135]; [@B45]; [@B113]; [@B133]). However mitochondrial differences exist between the stages of pluripotency, with primed ESCs containing more elongated mitochondria with better defined cristae compared to their naïve counterparts ([@B173]; [@B158]), despite the observation that primed ESCs have low mitochondrial activity, while naïve ESCs display active mitochondria ([@B173]; [@B138]; [@B131]). Although additional work is required to understand this apparent dichotomy between mitochondrial structure and function, it has been well established that mitochondria and metabolism play a critical role in the naïve-to-primed transition ([@B168]; [@B173]; [@B158]; [@B131]; [@B19]). For instance, a recent study demonstrated that loss of mitochondrial carrier homolog 2 (MTCH2), a direct regulator of mitochondrial fusion/elongation, resulted in less elongated and more fragmented mitochondria in mESCs, leading to delayed naïve-to-primed interconversion. This study indicated that MTCH2 is important for elongated mitochondria which itself was sufficient for driving naïve-to-primed interconversion by altering histone deacetylation and nuclear gene reprogramming ([@B4]). In addition, recent work has demonstrated that supplementation with a recombinant truncated human NME7 (NME7~*AB*~) is sufficient to induce a stable naïve-like state in hPSCs ([@B15]) associated with reactivation of mitochondrial function and stimulation of ATP production ([@B105]).

Despite the apparently immature mitochondrial structure in PSCs, they maintain high mitochondrial membrane potential, which helps to define their pluripotency and self-renewal characteristics ([@B119]; [@B3]; [@B92]; [@B112]). Indeed, mESCs with high mitochondrial membrane potential have the capacity to differentiate into the three germ layers, while those with low mitochondrial membrane potential differentiated mainly into mesodermal cells ([@B119]). Furthermore, fully reprogrammed iPSCs appear to have high mitochondrial membrane potential ([@B45]) and PSCs may actively maintain this potential by consuming ATP to enable reverse mode ATP synthase activity. Even though the underlying mechanism for maintaining high mitochondrial potential remains to be elucidated, it can impact stem cell function by: (a) maintaining a network of fragmented mitochondria ([@B97]; [@B168]; [@B143]), (b) maintaining redox potential ([@B125]), and (c) priming the cell to provide energy for differentiation ([@B42]). Thus, collectively these findings indicate that mitochondria play functional and developmental roles in metabolism of PSCs.

### Tricarboxylic Acid Cycle {#S2.SS2.SSS1}

The mitochondrial TCA cycle represents a central hub of energy metabolism, where many pathways involved in central carbon metabolism intersect. Canonically, this cycle predominantly oxidizes its major substrate, pyruvate, to CO~2~ in order to generate reducing factors and electron donors (NADH and FADH~2~) to supply the electron transport chain (ETC) and ATP synthesis. Complementing its role in energy generation, the TCA cycle also maintains a balance between anapleurosis, the reactions to replenish TCA intermediates using predominantly pyruvate and glutamine as substrates, and cataplerosis, whereby partially oxidized intermediates can be extracted to serve as building blocks for anabolic processes including lipid, amino acid and nucleotide biosynthesis, as well as post-translational modification of proteins ([@B161]; [@B8]). Through balancing energy generation with cataplerosis to supply substrates for anabolism and post-translational protein modification, the TCA cycle is critical for the regulation of stem cell function and fate.

Pluripotent stem cells appear to have reduced reliance on the canonical role of mitochondria for energy generation, which suggests that they repurpose their mitochondria for other purposes in support of stem cell maintenance. It appears that mitochondrial metabolism in PSCs involves incomplete oxidation of pyruvate, resulting in TCA cycle intermediates that are exported for myriad functions including anabolic reactions and histone modification. In fact, ESCs incompletely oxidize pyruvate through the TCA cycle generating citrate which is then transported and converted to acetyl-CoA through ATP-citrate lyase in the cytoplasm ([@B161]; [@B100]). While fatty acid oxidation (FAO) is known to contribute to the production of mitochondrial acetyl-CoA, its contribution to histone acetylation is limited. Cytosolic acetyl-CoA can serve as a substrate for a number of processes, including acetyl transferases that support the acetylation of many protein classes ([@B24]), as well as a precursor for *de novo* fatty acid synthesis ([@B162]; [@B14]; [@B100]). It was previously shown that early differentiation of ESCs was correlated to a reduced level of acetyl-CoA production and loss of histone H3 lysine 9 and lysine 27 acetylation, indicating that TCA-derived acetyl-CoA maintains an open chromatin state during pluripotency ([@B100]). Similarly, it was reported that inhibition of acetyl-CoA resulted in diminished histone acetylation, which in turn stimulated myogenic differentiation ([@B10]).

Like other highly proliferative cells, PSCs are dependent on glutamine, which enters the TCA cycle through initial conversion to glutamate by glutaminase, followed by conversion to αKG via glutamate dehydrogenase. αKG is a crucial cofactor for αKG-dependent dioxygenase enzymes, which include JHDMs and TET enzymes ([@B67]). The significance of αKG in regulation of pluripotency through epigenetic modifications has been previously demonstrated by several studies. Addition of cell-permeable dimethyl-αKG (dm-αKG) to culture media was shown to enhance self-renewal, while inhibiting the differentiation of mESCs by promoting histone and DNA demethylation ([@B14]). The beneficial effect of dm-αKG on pluripotency can be blocked through combined knockdown of the H3K9me2 demethylases, resulting in reduced colony formation. In corroboration with this finding, recent work revealed intracellular αKG can sustain mESCs and hESCs in a glutamine-independent manner ([@B150]). Expression of the pluripotent transcription factors, NANOG or KLF4, in the presence of 2i, resulted in an increased fraction of the TCA cycle intermediates generated from glucose-derived carbon in mESCs and hESCs ([@B150]). Since transient-glutamine depletion eliminated non-pluripotent cells, the authors emphasized that such metabolic rewiring can serve as a selection pressure for pluripotent cells over non-pluripotent cells. A recent study explored a potential functional link between oxidative metabolism, TCA cycle, and αKG on naïve to primed states of mESCs through single-cell analysis ([@B146]). The authors demonstrated that isocitrate dehydrogenase 2-mediated production of αKG was critical for sustaining naïve pluripotency in mESCs, even in the absence of 2i. Interestingly, the same study indicates that αKG also contributes to primordial germ cell differentiation ([@B146]). This observation is consistent with a previous report that high αKG and αKG-to-succinate ratio promotes differentiation of primed hESCs and mEpiSCs ([@B142]) through the regulation of histone methylation. This apparent dichotomy between the role of αKG in promoting pluripotency in naïve cells and promoting differentiation in the primed state indicates that metabolite signaling is very dependent on the developmental stage and specific cell type. Overall, the TCA cycle is at the metabolic crossroad contributing to cell fate by coupling its metabolites with both energy production and the chromatin landscape.

### Oxidative Phosphorylation {#S2.SS2.SSS2}

Oxidative phosphorylation is a critical pathway for maintaining bioenergetic homeostasis as it links multiple metabolic pathways including glycolysis, the TCA cycle, and FAO with ATP synthesis. This pathway enables electrons donated from NADH/FADH~2~ to flow down reduction potential gradients in the ETC and harnesses the energy produced to pump protons across the inner mitochondrial membrane to develop an electrochemical gradient. The transport of protons back across the membrane and into the mitochondrial matrix is performed by ATP synthase, which couples proton transport with ATP synthesis. Compared to glycolysis, OxPhos is a far more efficient pathway for ATP production, producing 36 ATP molecules per glucose, compared to 2 ATP molecules from glycolysis.

Pluripotent stem cells are typically considered to have a lower rate of OxPhos compared to their differentiated counterparts; however, the relative rate of OxPhos is highly dependent on the specific stage of pluripotency. Naïve PSCs display bivalent metabolism, consisting of both glycolysis and OxPhos, in contrast to primed PSCs which have very low rates of oxygen consumption and are almost entirely dependent on glycolysis despite displaying a more mature mitochondrial phenotype ([@B173]; [@B138]). Although RNA sequencing and microarrays have shown that mitochondrial electron transport genes are down regulated significantly in primed cells, they retain constant levels of mitochondrial DNA and display more elongated mitochondria with better defined cristae compared to their naïve counterparts ([@B131]). Indeed, recent work in canine ESCs (cESCs) has demonstrated that inhibition of complex I of the ETC did not alter the proliferation or viability of primed cESCs, while naïve cESCs were sensitive to complex I inhibition, thus supporting the differences in OxPhos dependency of these pluripotent stages. These metabolic preferences may not only be due to cellular ATP and anabolic demand but may also reflect the availability of oxygen and metabolic substrates during these specific stages *in vivo*. Changes in oxygen consumption have been reported during the transition from mouse preimplantation to early post-implantation development, and while these oxygen tensions are typically not maintained during *in vitro* culture, they may be related to the metabolic preferences of naïve vs. primed PSCs. Indeed, the bivalent metabolic phenotype of naïve PSCs may reflect the metabolic preference of the morula and blastocyst, which utilizes a combination of pyruvate oxidation and glycolysis to meet their metabolic demands, while primed PSCs become almost exclusively dependent on glycolysis, reflecting implantation into the hypoxic uterine wall. Indeed, the importance of reduced oxygen tension has been examined across a number of stem cell populations ([@B99]), including a role in improving the acquisition ([@B165]) and maintenance of pluripotency ([@B38]; [@B50]; [@B111]; [@B83]; [@B94]; [@B26]). In part these beneficial effects of physiologically relevant oxygen levels (2--5%) may be due to a reduction in mitochondrial function and oxygen utilization associated with elevated utilization of glucose via glycolysis and amino acid turnover ([@B49]; [@B25]; [@B148]; [@B82], [@B81]; [@B64]), although these metabolic changes can occur in the absence of changes in self-renewal ([@B64]). These effects of oxygen may be cell line dependent and may not occur in all iPSC lines, suggesting that metabolic fidelity may represent a marker for PSC and nuclear reprogramming quality ([@B82]; [@B62]; [@B132]). However, the effect of reduced oxygen tension on the transition between naïve and primed pluripotency, as well as the distinct metabolic phenotypes of these states have not been investigated.

Beyond its role in energy generation, the mitochondrial ETC also impacts a number of cellular processes including ROS production ([@B9]; [@B33]), mitochondrial membrane potential ([@B21]), and mitochondrial protein import ([@B54]), which may collectively impact self-renewal and proliferation. While several studies have demonstrated that inhibition of complex I or complex III is associated with impaired cell proliferation ([@B66]; [@B59]; [@B40]; [@B163]), the mechanism by which the ETC regulates cell proliferation has only recently been elucidated. Using a CRISPR-based genetic screen [@B7] revealed that the ETC enables the synthesis of aspartate, which is a precursor for purine and pyrimidine syntheses. To functionally validate the genetic screen, they demonstrated that supplementation with exogenous aspartate or overexpression of aspartate transporter enabled cells without ETC activity to proliferate, while loss of cytosolic aspartate aminotransferase (GOT1), which consumes aspartate to transfer electrons into mitochondria, resulted in cell death upon ETC inhibition. Collectively, this indicates that in addition to the canonical role of mitochondrial ETC in ATP synthesis, it also supports cell proliferation through the generation of aspartate, which functions as an anabolic substrate. In summary, both naïve and primed PSCs have active OxPhos, but the extent to which they rely on OxPhos for energy production and proliferation appears to differ due to the variances in the availability of oxygen and other metabolites that can sustain the high energetic demand of proliferation in PSCs.

Lipid Metabolism {#S2.SS3}
----------------

Lipids play vital roles in the maintenance of cellular homeostasis by serving as energy sources, signaling entities and building blocks for membranes. Lipid metabolism represents a carefully regulated balance between catabolism (FAO) and anabolism (*de novo* biosynthesis), which is highly dependent on the metabolic requirements of a specific cell state. FAO consists of active transport of medium and long chain fatty acids into the mitochondria through a regulated carnitine palmitoyl transferase system, with subsequent oxidation by the chain-length specific enzymes of beta-oxidation to generate acetyl-CoA that feeds into the TCA cycle and NADH that donates its electrons to the ETC. In contrast, *de novo* fatty acid biosynthesis requires substrates from multiple metabolic pathways, including acetyl-CoA, reducing factors and ATP, in order to build essential fatty acids. Despite the essential role of lipids in cellular homeostasis, the impact of lipids on PSC maintenance and self-renewal remains relatively unexplored in comparison with other metabolic pathways. Recent studies have begun to examine the impact of lipid availability on hPSCs metabolism and function ([@B167]; [@B29]) and demonstrated that lipid replete media (E8 and to a lesser extend mTeSR) significantly remodeled the metabolic state in order to sustain lipogenesis ([@B167]). The metabolic reprogramming induced by lipid deficiency significantly increased the oxidative PPP to support NADPH regeneration, increased glutamine consumption and fatty acid biosynthesis, at the expense of oxidative metabolism, which is consistent with the importance of glutaminolysis and the PPP to lipid biosynthesis in PSCs ([@B152]; [@B147]).

Lipid availability has also recently been shown to regulate the transition between naïve and primed hPSCs, with E8 medium inducing a primed-to-naïve intermediate state of pluripotency associated with increased *de novo* lipogenesis ([@B29]). The intermediate state in E8-hPSCs recapitulated many of the features of naïve pluripotency, however there were key differences, including a moderate state of DNA hypomethylation, specifically in terms of a global reduction in H3K27me3 and H3K9me3 levels, a known feature of naïve human PSCs. This intermediate state is dependent on lipid-free culture conditions, which promotes active lipid biosynthesis and endogenous ERK inhibition, features which are lost upon lipid supplementation. Interestingly, transcriptional analysis of E8-hPSCs and pre-implantation epiblasts demonstrated that *de novo* lipogenesis is a consistent transcriptional feature across *in vivo* and *in vitro* naïve pluripotency. The lipogenic state also supports the metabolic remodeling of the epigenome, including hyperacetylation of H3K27, H3K9 and H4K8 associated with increased acetyl-CoA metabolism and hypomethylation of DNA due to an increase in αKG to succinate ratio that activates JMJD and TET chromatin demethylases and a reduction in the SAM to S-adenosylhomocysteine (SAH) ratio. Indeed, this metabolic and epigenetic remodeling also increased the propensity for neuroectodermal differentiation, which is consistent with the observation that fatty acid synthase dependent-*de novo* lipogenesis is essential for neural stem cell proliferation and neurogenesis ([@B75]). Therefore, this data supports the concept that baseline pluripotent culture conditions have downstream effects on differentiation capacity.

In addition to their metabolic roles, lipids may also regulate the primed-to-naïve conversion as a signaling molecule ([@B74]). Lysophosphatidic acid (LPA) lipid signaling and the LPA-producing enzyme autotoxin have been implicated in establishing naïve PSCs in coordination with LIF and bone morphogenetic protein 4 (BMP4) signaling ([@B74]). These elegant studies support the importance of nutrient availability for defining stem cell features and suggest that manipulating energy metabolism may be sufficient to promote the transition between stem cell states. These studies indicate that metabolism is intertwined with epigenetics and the transcriptional landscape of PSCs, and additional work is required to determine how these pathways ultimately define the fate of PSCs.

Amino Acid Metabolism {#S2.SS4}
---------------------

Amino acids are important substrates for the biosynthesis of the basic building blocks of the cell, including proteins, lipids and nucleotides ([@B86]), and as such have been demonstrated to contribute significantly to the maintenance of pluripotency and stem cell fate. Beyond the direct anabolic roles of amino acids, such as *de novo* purine biosynthesis, amino acid metabolism is intimately related to one-carbon metabolism, which consists of the methionine and folate cycles that maintain cellular pools of one-carbon residues associated with S-adenosylmethionine (SAM) and folate ([@B27]). This one-carbon pool is not only essential for donating methyl groups for the synthesis of amino acids, nucleotides and phospholipids, but SAM also represents the principal substrate for post-translational methylation of RNA, DNA, and proteins, making it a critical connection between changes in metabolism and remodeling of the epigenetic state of the cell.

mESCs are highly dependent on threonine metabolism to maintain their pluripotency and self-renewal ([@B156]). Threonine dehydrogenase (TDH) and downstream enzymes in threonine metabolism, glycine c-acetyltransferase (GCAT) and glycine decarboxylase (GLDC), are highly expressed in mESCs and are rapidly downregulated during differentiation. Indeed, inhibition of TDH or complete removal of threonine from cell culture medium results in loss of stemness, reduced proliferation, apoptosis, and cell cycle arrest ([@B156]; [@B1]), while L-threonine supplementation and induction of TDH supports induction of pluripotency through nuclear reprogramming ([@B117]; [@B58]; [@B20]). The downstream effects of threonine metabolism on stem cell fate can be contributed to a number of mechanisms, including supplying methyl groups to the one carbon metabolism pool for the biosynthesis of cellular building blocks, as well as maintaining a high ratio of SAM to SAH to promote H3K4me3, which is critical for the maintenance of the pluripotent state ([@B6]; [@B156], [@B155]; [@B123]). L-threonine may mediate some of its proliferative effects through lipid raft/caveolae-dependent regulation of ERK, p38, JNK/SAPK, and mTORC pathways ([@B117]). In humans, TDH is only expressed as a non-functional pseudogene, thus hESCs rely on methionine metabolism in the same way that mESCs rely on threonine to maintain a high ratio of SAM/SAH ([@B121]). Interestingly, a recent study has also implicated methionine in mESC maintenance downstream of SIRT1 expression ([@B140]). SIRT1 KO mESCs display an elevated ratio of methionine/SAM due to a reduction in the expression of methionine adenosyltransferase 2a (MAT2a), which catalyzes the conversion of methionine to SAM ([@B140]). Regulation of methionine metabolism appears to be in part through a SIRT1-dependent protein expression of c-MYC and n-MYC, which bind to the MAT2a promoter and induce its expression. H3k27me3 is also regulated in the naïve state by N-methyltransferase, which consumes SAM, making it unavailable for histone methylation ([@B131]).

Proline may also play an important role in regulating PSC identity, as a feedback loop has been identified whereby proline modulates the GCN2-EIF2a-ATF4 amino acid starvation response pathway, which in turn suppresses proline biosynthesis to restrict proliferation and maintain ESC identity ([@B30]). Supplementation of mESC culture media with proline is sufficient to promote cell proliferation and transition of mESCs to EpiSCs ([@B159]; [@B16]), and induce ESCs into a mesenchymal-like, motile phenotype ([@B28]; [@B30]). Interestingly, this effect is completely reversible, as removal of proline results in the restoration of the mESC state. These phenotypic changes may in part be due to an increase in global H3K9 and H3K36 methylation, and can be reversed using vitamin C which promotes the demethylation of these marks ([@B28]). Ornithine supplementation can also induce a mESC to EpiSC transition, suggesting that this phenotype may be mediated through a common intermediate in the catabolism of proline and ornithine, namely Δ^1^-pyrroline-5-carboxylate ([@B16]). Collectively, these studies highlight the importance of proline in ESC identity, but further studies are required to decipher the underlying mechanism by which this amino acid impacts stem cell identity.

Energy Metabolism Drives Acquisition of Pluripotency Through Nuclear Reprogramming {#S3}
==================================================================================

Multiple studies have now demonstrated that remodeling of energy metabolism plays a critical role early during nuclear reprogramming of somatic cells into iPSCs ([@B137]), indicating that metabolic reprogramming in not simply a consequence on cell transition, but a driving force ([Figure 4](#F4){ref-type="fig"}). Upregulation of glycolysis has been demonstrated to precede the induction of pluripotency markers and is a critical component for successful nuclear reprogramming ([@B45]). Indeed cells that have a glycolytic phenotype reprogram more efficiently than those with greater reliance on OxPhos ([@B107]) and stimulation of glycolysis enhances reprogramming, while inhibition of glycolytic or stimulation of OxPhos suppresses reprogramming ([@B165]; [@B36]; [@B174]; [@B45]; [@B113]). Changes in protein expression of ETC subunits are among the earliest changes that occur during nuclear reprogramming ([@B60]), consisting of decreased expression of complex I and IV subunits and increased expression of complex II, III and V subunits. This reorganization of the ETC, particularly the reduced expression of complex I and increased expression of complex II, suggests that FADH~2~ may be the primary electron donor for ETC function during nuclear reprogramming and in the resultant iPSCs. Functionally, this manifests as a transient burst of OxPhos activity that accompanies the acceleration of glycolysis at the early stage of reprogramming ([@B113]; [@B70]; [@B65]). Indeed, increased ROS generated from OxPhos during this period may be critical for driving the metabolic transition during nuclear reprogramming through modification of cysteine residues on the NRG2 repressor protein KEAP1, leading to NRF2 activation, which subsequently activates HIF1α to support glycolysis ([@B95]; [@B65]). In addition, ZIC3 and ESSRB may act synergistically to promote glycolysis in a HIF-independent mechanism, while offsetting their opposing effects on OxPhos to promote both reprogramming and the conversion of primed PSCs into the naïve state ([@B129]). As reprogramming progresses, the abundance of mitochondrial DNA and mass gradually decrease as cells undergo autophagic mitochondrial clearance resulting in fewer spherical mitochondria with poorly developed and immature cristae compared to their parental fibroblasts ([@B45]; [@B112]; [@B91]). Mitochondrial fusion/fission dynamics are crucial for somatic cell nuclear reprogramming. Inhibition of the mitochondrial fission protein DRP1 is sufficient to suppress the early stage of reprogramming of somatic cells ([@B153]), while expression of mitochondrial fusion proteins, such as MFN1 and MFN2, appears to be a barrier for reprogramming ([@B128]). Inhibition of MFN1/MFN2 increases reprogramming efficiency by activating RAS/RAF signaling to enable ROS-mediated HIF1α stabilization to facilitate the transition of OxPhos to glycolytic metabolism ([@B128]). In summary, efficient nuclear reprogramming involves complex and stage specific metabolic changes driven by OxPhos and glycolysis.

![Metabolic remodeling drives nuclear reprogramming. Summary of the temporal changes in upstream regulators, the downstream metabolic changes and the consequences of this metabolic phenotype on nuclear reprogramming.](fcell-08-00087-g004){#F4}

Although metabolic remodeling has broadly focused on the transition from predominantly OxPhos to higher glycolytic activity upon nuclear reprogramming ([@B45], [@B44]; [@B113]; [@B13]), alternative metabolic pathways, including amino acid and lipid metabolism, are increasingly being identified to play an important role during nuclear reprogramming. As discussed earlier, threonine and methionine are indispensable amino acids to maintain the one-carbon pool that is essential for donating methyl groups for both anabolism and post-translation modifications. Indeed, L-threonine supplementation and induction of TDH supports induction of pluripotency through nuclear reprogramming by promoting H3K4me3 ([@B117]; [@B58]; [@B20]). Recent evidence has also implicated GLDC, a key enzyme in the glycine cleavage, in early metabolic remodeling during nuclear reprogramming and maintenance of the pluripotent state ([@B68]). GLDC expression occurs early in the reprogramming process and appears to be downstream of the reprogramming factors KLF4 and c-MYC, and reprogramming efficiency can be impaired with GLDC knockdown and enhanced with GLDC overexpression. GLDC knockdown in mESCs leads to a reduction in a number of glycolytic intermediates and the loss of self-renewal, suggesting that GLDC functions in reprogramming by regulating glycolysis ([@B68]).

*De novo* fatty acid synthesis also appears critical for acquisition and maintenance of pluripotency. Nuclear reprogramming is accompanied by enhanced lipogenesis due to increased expression of fatty acid synthase (FAS) and acetyl-CoA carboxylase 1 (ACC1) ([@B157]), and supplementation with exogenous oleic acid can increase reprogramming efficiency. Mechanistically, increased lipogenesis via ACC1 leads to enhanced mitochondrial fission by competing for a limited acetyl-CoA pool, thus blocking acetylation-dependent degradation of the mitochondrial fission 1 protein (FIS1) via the ubiquitin-proteasome pathway. In addition, increased lipid generation also drives mitochondrial dynamics toward a fission phenotype, which ultimately promotes nuclear reprogramming. Interestingly, FAO also appears to regulate nuclear reprogramming, consistent with its crucial role for oocyte and early embryo development ([@B103]; [@B35]; [@B122]). Long-chain FAO is primarily regulated by the transport of long-chain fatty acids (LCFA) across the inner mitochondrial membrane by the carnitine palmitoyltransferase (CPT) system, containing CPT1 and CPT2. CPT1b, which catalyzes the rate limiting transfer of the acyl group from coenzyme A to carnitine, was shown to be significantly upregulated at the early stage of reprogramming and overexpression of CPT1b improved reprogramming efficiency ([@B85]). Addition of palmitoylcarnitine (PC), the product of CPT1, was sufficient to stimulate OxPhos activity and enhance reprogramming only during the first 3 days of reprogramming, after which OxPhos was suppressed with PC supplementation, suggesting that the importance of FAO to reprogram may coincide with the hypermetabolic state observed early in the reprogramming process.

Although significant advances have been made in nuclear reprogramming technology, incomplete reprogramming can generate iPSCs that have transcriptional, epigenetic, and metabolic memory of their parental source ([@B18]; [@B73]; [@B104]; [@B79]; [@B132]). While the glycolytic phenotype of iPSCs and ESCs are in general very similar, differences have been identified in specific metabolites in human (polyunsaturated fatty acids, SAM) and mouse (phosphatidylcholine, phosphatidylethanolamine, amino acids and metabolites in polyamine biosynthesis) iPSCs compared to ESCs ([@B98]; [@B107]). Although these differences exist, their functional impact on maintenance of pluripotency or differentiation capacity have not been examined. Partially reprogrammed cells, which are characterized by forming stable ESC-like colonies but not expressing endogenous OCT4, NANOG, SSEA4 and TRA-1-60, appear to have a distinct mitochondria and metabolic profile that are intermediate between fully reprogrammed iPSCs/ESCs and parental fibroblasts in terms of mitochondrial morphology and gene expression, and concentrations of glycolytic and OxPhos intermediates ([@B78]; [@B109]). This insufficient repression of mitochondrial function and activation of glycolysis in partially reprogrammed cells can be rescued through microRNA 31 overexpression, which suppresses succinate dehydrogenase A activity to promote the transition from OxPhos to glycolysis and enhance reprogramming efficiency ([@B78]). Interestingly, recent evidence also indicates that dysregulated mitochondria fusion/fission dynamics impairs the ability to achieve full pluripotency and restricts developmental potential of iPSCs ([@B172]). Therefore, strategies that optimize mitochondrial and metabolic remodeling during nuclear reprogramming may improve reprogramming fidelity and ultimately their use in downstream applications.

Collectively, these studies demonstrate that complex and coordinated remodeling of energy metabolism is critical to drive efficient nuclear reprogramming, in part thought the resetting of the epigenetic landscape. While this appears to be the case in nuclear reprogramming, early metabolic remodeling may also play an important role in other cell state transitions, including from naive to primed pluripotency and release from pluripotency along lineage specific differentiation.

Summary {#S4}
=======

Over the past decade, significant advances have been made in our understanding of the metabolic requirements of stem cells and the important role that energy metabolism plays in regulating stem cell function and fate. An emerging concept supports metabolism as not simply a homeostatic system that matches energy supply with energetic demands, but a critical early step during transition between cellular states. This concept is backed by two observations: a) metabolic changes are often some of the earliest to occur during cell fate transitions and b) there is growing appreciation that metabolic pathways directly contribute to the epigenetic remodeling of the cell. This realization has placed emphasis on understanding the microenvironment in which these cells are cultured, as numerous studies have now shown that modifying availability of a single metabolic substrate can dramatically impact stem cell identity. As the field increasingly dissects the finer metabolic distinctions between pluripotent states and discovers how these interact with regulators of stem cell fate, it will be interesting to see if manipulation of substrate supply and energy metabolism may help to enable the derivation and culture of other PSC states, such as totipotent stem cells or formative PSCs. In addition, modulation of energy metabolism may ultimately be harnessed for translational and clinical applications, not only to support manufacturing and lineage specification of PSCs for regenerative therapies, but also to promote innate regenerative capacity and augment current cell-based therapies.
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